Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristine H Allin

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Critical Reviews in Clinical Laboratory Sciences|November 1, 2011
Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancerKristine H Allin, Børge G Nordestgaard
Diabetologia|January 21, 2014
Pleiotropic effects of HNF1A rs1183910 in a population-based study of 60,283 individualsKristine H Allin, Børge G Nordestgaard
European Journal of Endocrinology|November 23, 2014
Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitusKristine H Allin, Trine Nielsen, Oluf Pedersen
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 14, 2019
ReplyMarie Villumsen, Tine Jess, Kristine H Allin
Gastroenterology|November 26, 2023
ReplyManasi Agrawal, Jean-Frederic Colombel, Kristine H Allin
Gastroenterology|September 28, 2021
Ultraprocessed Foods and the Risk of Inflammatory Bowel Disease: Is it Time to Modify Diet?Kristine H Allin, Ryan C Ungaro, Manasi Agrawal
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Baseline C-reactive protein is associated with incident cancer and survival in patients with cancerKristine H Allin, Stig E Bojesen, Børge G Nordestgaard
Ugeskrift for Laeger|December 4, 2009
[C-reactive protein, risk of and survival after cancer--secondary publication]Kristine H Allin, Stig E Bojesen, Børge G Nordestgaard
International Journal of Cancer|May 20, 2016
Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general populationKristine H Allin, Stig E Bojesen, Børge G Nordestgaard
JAMA Network Open|September 30, 2022
Comparative Outcomes and Safety of Vedolizumab vs Tumor Necrosis Factor Antagonists for Older Adults With Inflammatory Bowel DiseasesSiddharth Singh, Aske T Iversen, Kristine H Allin, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Critical Reviews in Clinical Laboratory Sciences|November 1, 2011
Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancerKristine H Allin, Børge G Nordestgaard
Diabetologia|January 21, 2014
Pleiotropic effects of HNF1A rs1183910 in a population-based study of 60,283 individualsKristine H Allin, Børge G Nordestgaard
European Journal of Endocrinology|November 23, 2014
Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitusKristine H Allin, Trine Nielsen, Oluf Pedersen
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 14, 2019
ReplyMarie Villumsen, Tine Jess, Kristine H Allin
Gastroenterology|November 26, 2023
ReplyManasi Agrawal, Jean-Frederic Colombel, Kristine H Allin
Gastroenterology|September 28, 2021
Ultraprocessed Foods and the Risk of Inflammatory Bowel Disease: Is it Time to Modify Diet?Kristine H Allin, Ryan C Ungaro, Manasi Agrawal
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Baseline C-reactive protein is associated with incident cancer and survival in patients with cancerKristine H Allin, Stig E Bojesen, Børge G Nordestgaard
Ugeskrift for Laeger|December 4, 2009
[C-reactive protein, risk of and survival after cancer--secondary publication]Kristine H Allin, Stig E Bojesen, Børge G Nordestgaard
International Journal of Cancer|May 20, 2016
Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general populationKristine H Allin, Stig E Bojesen, Børge G Nordestgaard
JAMA Network Open|September 30, 2022
Comparative Outcomes and Safety of Vedolizumab vs Tumor Necrosis Factor Antagonists for Older Adults With Inflammatory Bowel DiseasesSiddharth Singh, Aske T Iversen, Kristine H Allin, et al.
Pageof 10